- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05912842
Forging Sustainable Solutions for HIV Continuity of Care Through Medical-legal Partnerships
June 21, 2023 updated by: Temple University
The goal of this study is to test the Organizational Partnerships for Healthy Living (OPAHL) intervention through a feasibility and acceptability trial.
OPAHL is an innovative, multilevel intervention package intended for health care organizations serving people living with HIV (PLWH).
It was developed through a prior study (grant #: R21 MH115820) using intervention mapping methodology and community-scientific collaborative boards.
OPAHL consists of: 1) training (7/8hours) for all MLP staff (clinical, social and behavioral services, and legal) on HIV continuum of care, health harming legal risks and needs, and MLP structure and operations to ensure that an integrated and collaborative environment is established from the earliest stages of the program; 2) case management training on the legal continuum of care; 3) embedding of legal expertise within regularized case management team meetings; 4) co-location of legal services in health care agencies through MLP inter-organizational partnership within 3 months; and 5) organizationally tailored implementation of best-practice communication and information-sharing protocols among providers within MLP, anchored in patient autonomy and choice.
The specific aims of this study are: 1) to refine the OPAHL intervention prototype for implementation with PLWH with detectable viral loads and 2) to test the feasibility, acceptability and preliminary effects sizes of OPAHL.
Given the current COVID-19 pandemic, the study will also explore MLP opportunities that respond at the intersection of HIV/AIDS and COVID-19 prevention and treatment.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
A health-harming legal need is a social problem that adversely affects a person's health or access to health care and which is better remedied through the combination of legal care and health care.
Medical legal partnerships (MLPs) have been underutilized as structural interventions; however, they could help improve HIV care continuum outcomes in health care organizations.
The goal of this study is to test the Organizational Partnerships for Healthy Living (OPAHL) intervention through a feasibility and acceptability trial.
OPAHL is an innovative, multilevel intervention package intended for health care organizations serving people living with HIV (PLWH).
It was developed through a prior study (grant #: R21 MH115820) using intervention mapping methodology and community-scientific collaborative boards.
OPAHL consists of: 1) training (7/8hours) for all MLP staff (clinical, social and behavioral services, and legal) on HIV continuum of care, health harming legal risks and needs, and MLP structure and operations to ensure that an integrated and collaborative environment is established from the earliest stages of the program; 2) case management training on the legal continuum of care; 3) embedding of legal expertise within regularized case management team meetings; 4) co-location of legal services in health care agencies through MLP inter-organizational partnership within 3 months; and 5) organizationally tailored implementation of best-practice communication and information-sharing protocols among providers within MLP, anchored in patient autonomy and choice.
The specific aims of this study are: 1) to refine the OPAHL intervention prototype for implementation with PLWH with detectable viral loads and 2) to test the feasibility, acceptability and preliminary effects sizes of OPAHL.
Given the current COVID-19 pandemic, the study will also explore MLP opportunities that respond at the intersection of HIV/AIDS and COVID-19 prevention and treatment.
Two health care organizations serving PLWH Philadelphia, PA that do not currently provide any form of legal services to their patients will participate in this trial (n=200 PLWH).
The proposed study is in response to PA-20-141: Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional).
It is also responsive to two of the areas of high priority research of NIMH Division of AIDS Research (Develop and test interventions to improve HIV treatment outcomes; Advance the development and testing of interventions delivered beyond the individual level).
Completion of this project will result in the development of an intervention package to optimize HIV services for a highly vulnerable population whose HIV care is affected by health-harming legal needs.
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Omar Martinez, JD
- Phone Number: 7862084340
- Email: omar.martinez@ucf.edu
Study Contact Backup
- Name: Miguel Munoz-Laboy, DrPH
- Email: miguel.munoz-laboy@stonybrook.edu
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19102
- Recruiting
- TPAC
-
Contact:
- Omar Martinez
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Living with HIV (as confirmed by medical record)
- 18 years or older
- HIV viral load of more than 200 copies/mL (as confirmed by medical record)
- Willing and able to consent to participate in the trial (including accessing their medical records at the health care organization)
- No intent to relocate within the 6 months following their enrollment in the study
Exclusion Criteria:
-Individuals who self-report having been sentenced to serve under state or federal custody, with a sentence to begin within 6 months from proposed enrollment in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Medical Legal Partnerships
Component 1 is a comprehensive training for all MLP care providers delivered to clinical, social and behavioral, and legal staff together to establish a collaborative environment.
Component 2 consists of the screening tool and screening protocol that is designed to identify health-harming legal needs of PLWH patients.
Component 3 includes the provision of legal support through partnership with the Legal Clinic for the Disabled.
Upon a positive legal needs screening, the case manager connects the patient to this attorney, at which point the patient, after signing a letter of engagement, becomes a client and can now address the identified legal issue(s) with legal representation.
|
Component 1 is a comprehensive training for all MLP care providers delivered to clinical, social and behavioral, and legal staff together to establish a collaborative environment.
Component 2 consists of the screening tool and screening protocol that is designed to identify health-harming legal needs of PLWH patients.
Component 3 includes the provision of legal support through partnership with the Legal Clinic for the Disabled.
Other Names:
|
|
Active Comparator: Standard of Care
Comparison arm health organization will only receive the HIV standard of care (U.S. CDC HIV standard of care) and referral to legal aid.
|
Comparison arm health organization will only receive the HIV standard of care (U.S. CDC HIV standard of care) and referral to legal aid.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Viral Suppression
Time Frame: 6 months
|
HIV viral load through HIV Nucleic Acid Amplification Test (NAAT) HIV by PCR HIV RNA Test
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement in HIV Care
Time Frame: 6 months
|
HIV primary care appointments and services at health organization (Attendance in the prior 3 months)
|
6 months
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10
Time Frame: 6 months
|
The Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10 is a gauge of general healthcare-related quality of life.Response options are presented as 5-point (as well as a single 11-point) rating scales.
The scores are then standardized to the general population, using the "T-Score".
The average "T-Score" for the United States population is 50 points, with a standard deviation of 10 points.
Higher scores indicate a healthier patient.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2022
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
June 1, 2024
Study Registration Dates
First Submitted
June 12, 2023
First Submitted That Met QC Criteria
June 12, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
June 23, 2023
Last Update Submitted That Met QC Criteria
June 21, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- R34MH125718 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Organizational Partnerships for Healthy Living
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedOrganizational Support for Evidence-based Public HealthUnited States
-
University of California, IrvineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy | Living Kidney DonationUnited States
-
George Washington UniversityJohns Hopkins University; National Institutes of Health (NIH); Bill and Melinda... and other collaboratorsCompletedPregnancy and Early Lactation Among Women Living in an Area Endemic for MalnutritionNepal
-
Danone ResearchCompletedHealthy Free-living ElderlyBelgium
-
Universitaire Ziekenhuizen KU LeuvenNorgine BVActive, not recruitingHealthy | Bowel Preparation | Bowel Preparation for Colonoscopy | Bowel Cleansing for ColonoscopyBelgium
-
National Sun Yat-sen UniversityNot yet recruitingChronic Insomnia Characterized | Difficulty Falling Asleep | Difficulty Maintaining Sleep | Healthy Aging and Independent Living
-
Alphatec Spine, Inc.RecruitingHealthy | Indicated for EOSedge ImagingUnited States
-
Gangnam Severance HospitalActive, not recruitingHealthy Donors for Liver TransplantationKorea, Republic of
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | PK for FG-4592Germany
-
SyntheticMRCompletedHealthy Volunteers | Clinical Indication for Brain MRIUnited States
Clinical Trials on Organizational Partnerships for Healthy Living
-
University of Central FloridaNational Institute of Mental Health (NIMH); University of Miami; Hope and Help...Recruiting
-
Tufts UniversityTufts Clinical and Translational Science InstituteTerminated
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); University of California, Davis; Chinese... and other collaboratorsCompletedSmoking Cessation | Health Behavior | FamilyUnited States
-
Tufts UniversityUnited States Army Research Institute of Environmental MedicineCompleted
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingIncorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism (ERASE-PE)Acute Pulmonary EmbolismUnited States
-
Rhode Island HospitalRecruitingAlzheimer DiseaseUnited States
-
Massachusetts General HospitalDuke University; Rush University Medical Center; National Center for Complementary...CompletedChronic PainUnited States
-
University of WashingtonAsian American Resource and Information Network, Inc.CompletedDepression | Sleep | Anxiety Depression | Mindfulness Based Cognitive TherapyUnited States
-
Boston CollegeMassachusetts General Hospital; Harvard School of Public Health (HSPH); University... and other collaboratorsTerminatedObesity | Pediatric ObesityUnited States
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada